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Augmentation of regenerative osteogenesis represents a premier clinical need, as hundreds of thousands
of patients are left with insufﬁcient healing of bony defects related to a host of insults ranging from
congenital abnormalities to traumatic injury to surgically-induced deﬁcits. A synthetic material that
closely mimics the composition and structure of the human osteogenic niche represents great potential
to successfully address this high demand. In this study, a magnesium-doped hydroxyapatite/type I
collagen scaffold was fabricated through a biologically-inspired mineralization process and designed to
mimic human trabecular bone. The composition of the scaffold was fully characterized by XRD, FTIR, ICP
and TGA, and compared to human bone. Also, the scaffold microstructure was evaluated by SEM, while
its nano-structure and nano-mechanical properties were evaluated by AFM. Human bone marrow-
derived mesenchymal stem cells were used to test the in vitro capability of the scaffold to promote
osteogenic differentiation. The cell/scaffold constructs were cultured up to 7 days and the adhesion,
organization and proliferation of the cells were evaluated. The ability of the scaffold to induce osteogenic
differentiation of the cells was assessed over 3 weeks and the correlate gene expression for classic genes
of osteogenesis was assessed. Finally, when tested in an ectopic model in rabbit, the scaffold produced a
large volume of trabecular bone in only two weeks, that subsequently underwent maturation over time
as expected, with increased mature cortical bone formation, supporting its ability to promote bone
regeneration in clinically-relevant scenarios. Altogether, these results conﬁrm a high level of structural
mimicry by the scaffold to the composition and structure of human osteogenic niche that translated to
faster and more efﬁcient osteoinduction in vivo e features that suggest such a biomaterial may have
great utility in future clinical applications where bone regeneration is required.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Bone augmentation is deﬁned as the increase in osseous di-
mensions achieved via the addition of material or tissue [1]. It has
become common clinical practice in a variety of medical conditions
in which functional restoration of damaged bone is needed - such
as traumatic injury, degenerative diseases, congenital deformities,Ltd. This is an open access article ucancer, or in post-operative defects [2,3]. Autologous trabecular
bone is widely regarded as the standard for bone augmentation,
supplying growth factors, cells and a mechanical support for tis-
sue's structure [4,5]. The iliac crest is currently the principal source
of autologous bone for such applications, however, donor site
morbidity, higher care cost from longer hospital stays or surgical
complication, and additional subsequent surgery are just some of
several limitations of this approach [4,6]. Allografts have been
investigated as an alternative strategy, but immunogenic rejection
and risk for disease transmission have never been fully resolved [7].
These limitations have spurred the development of a plethora ofnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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vantages of off-the-shelf materials include: lower cost, biocom-
patibility, biosafety, lower risk of rejection and simpliﬁcation of the
procedure to a single operation [9]. First generation synthetic ma-
terials were lacking in osteoinductive and osteogenic elements and
their rate of success was inferior to autologous or allogenic bone
grafts [10]. More recent decades have witnessed great progress in
understanding the key osteogenic cues that synthetic materials
must provide for efﬁcient bone formation to occur [11e13]. Several
strategies have been proposed to develop materials integrated with
regenerative growth factors (GFs) [14,15], or GFs delivery systems in
order to avoid disruptive side effects [16e20]. One particular
example of this technology that saw widespread use is the com-
bination of a simplistic collagen sponge with recombinant human
bone morphogenic protein 2 (INFUSE®, Medtronic, Memphis, TN,
USA). Unfortunately, off-label use of this product has been fraught
with complications ranging from dysphaghia and/or dysphonia to
retrograde ejaculation and even a trend toward increased cancer
incidence. Perhaps the incidence of adverse effects with the use of
such synthetic products could be decreased by improving the
biomaterial matrix; or the requisite dose required for effect could
be diminished, thus reducing dose-dependent clinical complica-
tions [19,21,22].
The ideal material for bone augmentation should not only be
osteoconductive but osteoinductive, exploiting the self-healing
capabilities of the patient via: (i) recruiting progenitor cells and
promoting their proliferation and differentiation; (ii) providing the
main structural building blocks for the formation of new tissue;
(iii) biocompatibility. The current approach to achieve these goals
is biomimicry, which aims to design materials that closely
resemble the target tissue [23]. So far, biomimicry has proven a
powerful strategy in the development of bone substitutes. The
most common examples are based on calcium phosphates (e.g.
hydroxyapatite), which is the main component of bone [24,25].
However, bone extracellular matrix (ECM) is also formed by an
organic component, which acts as a template for the mineral
phase deposition e a process dependent on type I collagen [26].
The structure of the organic matrix has a fundamental role in the
mineralization of bone, as it not only directs the mineral deposi-
tion, but also guides their growth, by the interaction of its func-
tional groups (e.g. carbonyl groups) [27] with apatite crystals. Such
highly regulated chemical-physical interaction between the inor-
ganic and organic phase is fundamental to allow for the formation
of a composite material (bone) with unique properties of both
stiffness (minerals) and elasticity (collagen) [28]. Also, the hy-
droxyapatite within bone is characterized by a multitude of doping
ions that substitute either calcium or phosphate in the crystal
lattice [29]. Magnesium is one of the main ions found in young
bone or newly formed bone, which are characterized by a faster
turnover [30]. Thus, the simulation of such ECM by synthetic
substitutes could theoretically signiﬁcantly enhance bone
formation.
In this study, we aimed to manufacture and characterize a
composite material able to recapitulate the chemical-physical and
morphological cues of young human osteogenic niche as a po-
tential robust substitute for bone augmentation. Our working
hypothesis was that mimicry of the composition and structure
of the osteogenic niche within a composite scaffold would facili-
tate osteogenesis in vitro and bone formation at an ectopic site. In
an attempt to mimic the newly formed bone niche and test
our hypothesis, we developed a bio-inspired, nanocrystalline
magnesium-doped hydroxyapatite/type I collagen composite
scaffold (MHA/Coll). Its osteoinductive potential was initially
determined in vitro using human bone marrow-derived mesen-
chymal stem cells (hBM-MSC) over a 3-week period, then itseffectiveness in promoting new bone formation was assessed
in vivo using an ectopic rabbit model.
2. Materials and methods
2.1. MHA synthesis
Magnesium-doped hydroxyapatite (MHA) powders were pre-
pared at 37 C in air atmosphere by dropping 300 mL of an aqueous
solution containing 44.4 g of H3PO4 (Aldrich, 85% pure) into basic
suspensions consisting of 50 g Ca(OH)2 (Aldrich, 95% pure) and
different amounts of MgCl2$6H2O (Merck, A.C.S., ISO) in 500 mL of
water. The apatitewas let ageing for 24 h at room temperature, then
washed with DI water and freeze dried.
2.2. Scaffold synthesis
Type I collagen from bovine tendon (Nitta Casing) was the
organic matrix used for the synthesis of MHA/Coll. The collagen
was dissolved at a concentration of 10 mg/mL in an aqueous acetic
buffer solution at pH 3.5. MHA nanocrystals were directly nucle-
ated on the collagen ﬁbrils, during their pH-driven self-assem-
bling. Brieﬂy, 40 mM aqueous solution of H3PO4 was added to 40 g
of the acetic collagen gel, and dropped in a aqueous 40 mM basic
suspension of Ca(OH)2 and MgCl2$6H2O. MgCl2$6H2O was added
to the basic solution to obtain a teoric 5% sobsitution of calcium in
the ﬁnal apatite lattice the material underwent a wet crosslinking
in a aqueous solution of 1,4-butanediol diglycidyl ether (BDDGE)
(2.5 mM), at 4 C. After this step, the material was washed several
times with distilled water to eliminate any residual solvent and
crosslinking solution. The slurry was adjusted in 48-well plates
(2 mm height), to fabricate the scaffold for the in vitro studies,
while for the in vivo studies we utilized a cylindrical mold
(4 cm  1 cm). The ﬁnal porosity of the scaffold was generated by
freeze drying. Brieﬂy, the materials was frozen from þ20 C
to 20 C in 3 h, and then heated from 20 C to þ20 C in 3 h
under vacuum conditions (80 mTorr). Non-mineralized collagen
scaffolds (Coll) were also synthesized as described above, from an
acetic collagen slurry (10 mg/mL), which was precipitated to pH
5.5 with NaOH (1.67 mM). Collagen was washed with DI as well,
and scaffolds were prepared with the same freeze drying process
followed for MHA/Coll. All chemicals were purchased from Sigma
Aldrich.
2.3. Compositional characterization of MHA/Coll
X-ray diffraction (XRD) patterns were recorded by a Bruker AXS
D8 Advance instrument, in reﬂection mode with Cu Ka radiation.
The samples were mounted on a customized support to obtain
relatively uniform samples. Fourier-transformed Infrared spec-
troscopy (FTIR) was performed using a Nicolet 4700 Spectroscopy
on pellets (10 mm in diameter) which were prepared by mixing
2 mg of grounded sample with 100 mg of KBr in a mortar and
pressing to produce the pellet to be analyzed. Spectra were
analyzed by the software EZ OMNIC (Nicolet) after baseline
correction.
Inductively coupled plasma e atomic emission spectrometry
(ICP-AES: Liberty 200, Varian, Clayton South, Australia), was
applied to determine the content of Mg2þ, Ca2þ, PO43 ions consti-
tuting the mineral phase forming the composite. Samples were
previously prepared by acid attack with nitric acid 65 wt%. The
obtained values were expressed in terms of Ca/P and Mg/Ca molar
ratios. Thermal gravimetric analysis and differential scanning
calorimetry were performed though a TGA/DSC thermogravimetric
analyzer (METTLER TOLEDO), by placing the samples in alumina
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10 C/min.2.4. Structural characterization of MHA/Coll
Coll and MHA/Coll morphology was evaluated and compared to
that of human trabecular bone by scanning electron microscopy
(SEM) (Quanta 600 FEG, FEI Company, Hillsboro, OR). Scaffolds
were compared to human trabecular bone specimens, which were
decellularized and dehydrated according to established protocols
[31]. Freeze dried samples were sputter coated with 10 nm of Pt/Pd
and imaged at a voltage of 10 mA.
The Atomic Force Microscopy (AFM,Bruker MultiMode 8) mea-
surements were obtained using ScanAsyst-air probes, and the
spring constant (Nominal 0.4 N/m, radius 2 nm) and deﬂection
sensitivity has been calibrated. From the bulky scaffold we removed
some ﬁbers, we suspend them in MQ water and then we let them
dry on a mica surface. All presented AFM images are height and
phase data and images within each ﬁgure are on the same height
scale and have been subject to the 1 order of ﬂattering.
AFM images were collected from different samples and at
random spot surface sampling (at least ﬁve areas per sample). The
quantitative roughness (Ra) data was obtained by Bruker software
(NanoScope Analysis) on sampling areas of 100 nm2, randomly
analyzed on 4 different images [32].
Quantitative mechanical characterizationwas determined using
the same instrument, operated under peak-force tapping mode
with 1.0 Hz scan rates and a 200 mV amplitude set point. To
calculate the Young's modulus, the retract curve of the force versus
separation plots could be ﬁtted by the DMT model [33]:
F  Fadh ¼ 4=3 E*
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Rðd d0 Þ
q 3
F e Fadh is the force on the cantilever relative to the adhesion
force, R is the tip radius, d e d0 is the deformation of the sample,
and E* is the reduced modulus. The Young's modulus measurement
has been calculated on a sample corresponded to 512  512
forceeseparation curves obtained over an area 1.7 mm  1.7 mm.2.5. hBM-MSC culture
hBM-MSC cultures were established following the manufac-
turer's instructions (Gibco). Adherent cells were serially passaged
using TripLE™ Express (Invitrogen) upon reaching near conﬂuence
(80%) and then reseeded for culture maintenance.2.6. Cell organization and morphology in 3D culture
To be seeded into scaffolds, hBM-MSC were harvested and
resuspended in standard cell culture medium. A drop of 30 ml
containing 350,000 cells was seeded on the center of each scaffolds
(either collagen or MHA/Coll) and kept in incubator for 10 min.
Culture medium was then added to each well. Cell morphology in
2D culture was evaluated by staining with phalloidin and DAPI
according to manufacturer's protocols (Life Technology), while in
3D by staining with LIVE/DEAD®. Images were acquired by confocal
laser microscopy. The scaffold was imaged exploiting its auto-
ﬂuorescence at 358/461 nm. Cell viability on the scaffolds was
evaluated by LIVE/DEAD® cell viability assay, which was performed
according to manufacturer protocol. Samples were imaged by an
Eclipse Ti ﬂuorescence microscope (NIKON) and cell viability was
calculated via an automatedmeasurement tool of the NIS-Elements
Software (NIKON).2.7. Cell proliferation on scaffolds
Cell proliferation in the scaffolds was evaluated by Alamar Blue
assay (Invitrogen) according to manufacturer's instructions.
Absorbance was measured at a wavelength of 570 and 600 nm.
Three days after seeding, hBM-MSC were stained using a ﬂuores-
cent Live-Dead Viability Assay (Molecular Probes, Eugene, OR) ac-
cording to the manufacturer's instructions and captured on a A1
confocal laser microscope (NIKON).
2.8. hBM-MSC osteogenic differentiation
The osteogenic potential of MHA/Coll has been evaluated over a
21-days period. hBM-MSC at passage 3 were seeded onto Coll and
MHA/Coll at the density of 10,000/cm2. hBM-MSC cultured in 2D
conditions, either exposed to inducing media (StemPro® Osteo-
genesis Differentiation Kit, Gibco) or kept in standard media were
used as positive and negative controls, respectively. Media changes
were performed every three days.
2.9. Gene expression analysis
To conﬁrm the osteogenic induction, total RNA was isolated
from cells grown on scaffolds by homogenization in 1 mL of Trizol
reagent (Life Technologies) according to the manufacturer's in-
structions with a Power Gen 125 tissue homogenizer (Fisher Sci-
entiﬁc). For each sample, RNA concentration and purity were
measured using Nanodrop Spectrophotometer (Nanodrop®
ND1000). Treatment with DNAse (Sigma) was performed to avoid
DNA contamination. cDNA was synthesized from 1 ml of total RNA
using Taqman Reverse Transcription reagents kit (Applied Bio-
systems, Branchburg, NJ). Ampliﬁcations were set on plates in a
ﬁnal volume of 10 ml and carried out using TaqMan® Fast Advanced
Master Mix and TaqMan Probes (Applied Biosystems). The
expression of osteocalcin (BGLAP; Hs01587814_g1), osteopontin
(SPP1; Hs00959010_m1) and alkaline phosphatase (ALP;
Hs01029144_m1) was assessed. The expression of osteogenic spe-
ciﬁc genes of hBM-MSC cultured on MHA/Coll was compared to
that of cells on collagen scaffolds (Coll), and cells cultured in 2D
conditions with osteogenic media (MSC-induced), or not (MSC-
ctrl). Results were normalized to the level of glyceraldehyde 3-
phosphate dehydrogenase (GAPDH; Hs02758991_g1) and repre-
sented with respect to MSC-ctrl.
2.10. Subcutaneous implantation of MHA/Coll
Skeletally mature New Zealand white rabbits were used for the
purpose of this study. All animals were maintained and used in
conformity with the guidelines established by American Associa-
tion for Laboratory Animal Science (IACUC). In prone position and
under the effects of surgical anesthesia; with the use of sterile
technique, three incisions were made on the back of each animal.
Using blunt dissection, the subcutaneous pockets were created.
One scaffold (1 cm diameter x 3 cm long) was implanted subcu-
taneously into each pocket. Each rabbit was implanted with 3
scaffolds. After placement of implants, the incisions were closed
with staples.
2.11. DynaCT analysis of specimens
Under the effects of sedation, lumbosacral computed tomogra-
phy (DynaCT) scans were obtained from all animals at 24h, 2, 4 and
6 weeks post-surgery. Scanning was performed using a Siemens
Axiom Artis C-arm (d)FC (Siemens Healthcare, Erlangen, Germany),
with a 48 cm  36 cm ﬂat-panel integrated detector. Acquisition
Fig. 1. XRD spectra of human trabecular bone (blue) and MHA (green) (A), compared to MHA/Coll (B). FTIR spectra of Coll, MHA, MHA/Coll respect to that of bone (C). (For
interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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matic tube current of 107 mA, 20 s scan. Each scan entailed 222
degrees of rotation, with 1 image taken every 0.5 for a total of 444
images (each digital acquisition had a matrix of 514x514 pixels) per
acquisition. Three-dimensional bone deposition analysis was per-
formed on every CT scan with the use of the Inveon Research
Workplace 4.2 Software (Siemen Medical Solution, USA, Inc.).
2.12. Statistical analysis
Statistics were calculated with Prism GraphPad software. Sta-
tistics for experiments was performed using a Two-Way ANOVA
followed by a Tukey's multiple comparison test. In all cases * was
used for p < 0.05, ** for p < 0.01, and *** for p < 0.001, and **** for
p < 0.0001. All experiments were performed at least in triplicates.
Data is presented as mean ± SD.
3. Results
3.1. Characterization of the chemical composition of MHA/Coll
Compared to commercially available stoichiometric hydroxy-
apatite (Fig. S1), MHA (green) was characterized by low crystal-
linity, and a similar pattern to that of the mineral phase of human
bone (blue), which displayed almost identical shape (Fig. 1A). It was
observed, that Bone was slightly more amorphous than bone, as
evidenced by broader peaks. However, when such MHA was
nucleated, through our biologically inspiredmineralization process,
onto highly structured type I collagen ﬁbers, the result was the
composite MHA/Coll, which displayed a pattern typical of amor-
phous phases (Fig. 1B).
We further investigated the chemical interaction between the
mineral phase MHA and the ﬁbers of collagen with FTIR spectros-
copy (Fig. 1C). A shift from 1340 to 1337 cm-1 of the band corre-
sponding to the stretching of eCOO- group of collagen was
observed, which is representative of collagen's functional groupTable 1
Chemical composition of MHA/Coll obtained by ICP-AES.
Sample labels Ca (A) 422.673 Mg (A) 280.270 PO4 (A) 213.618
Standard 1 ppm 80 5 98
ml 40 2,5 16
MHA/Coll
ppm 40,429 0,9263 61,398
mole 1009 0.038 0.646
Ca/P 1561
Ca þ Mg/P 1620
Mg/Ca % 3,78interacting with the positively charged apatite nanocrystals. The
band at 872 cm-1, indicating the carbonation of the MHA that was
nucleated on the collagen, resulted more intense.
Table 1 reports the results of the ICP analysis of MHA/Coll. The
average value of the Ca/P ratio of MHA nucleated on collagen was
1.561, which is in the range of low crystalline apatite (1.45e1.60);
the presence of HPO42 in low crystalline apatites is responsible of a
decrease in this ratio. The amount of magnesium substituting cal-
cium was about 76% of the starting nominal concentration of
magnesium, and resulted in the substitution of 3.78%.
TGA was performed to quantify the amount of mineral phase
which could be nucleated on the collagen in the MHA/Coll com-
posite. This experiment revealed that the mineral phase content
was the 56 wt% in MHA/Coll, and that it corresponded to that of
human trabecular bone (53 wt%) (Fig. 2).3.2. Morphological characterization of MHA/Coll
Coll and MHA/Coll structures were evaluated by SEM (Fig. 3).
Coll scaffold (Fig. 3A) revealed pores in the order of about 200 mm
(Fig. 3B), and collagen ﬁbers were highly structured, preserving
their typical bands (Fig. 3C). MHA/Coll proved to be very different
with respect to Coll at a ﬁrst gross evaluation (Fig. 3D). Its SEM
micrographs showed the presence of more anisotropic pores at
lower magniﬁcation (Fig. 3E). At higher magniﬁcation MHA/Coll
appeared signiﬁcantly different with respect to Coll (Fig. 3F), as
pores were not as deﬁned and a more ﬁbrous structure was found.
Fig. 3G shows a single ﬁber of the mineralized collagen of the
scaffold MHA/Coll: the collagen ﬁber appeared wider in diameter,
being completely ﬁlled and covered by an amorphous mineralFig. 2. Weight percentage of mineral phase nucleated on the collagen in MHA/Coll
sample, compared to that of bone, by TGA.
Fig. 3. Picture of Coll (A) and SEM micrographs at 200 (B) and 25000 (C). Photography of MHA/Coll (D) and SEM micrographs at the two different magniﬁcations, respectively (E,
F). SEM image of a collagen ﬁber of MHA/Coll, completely mineralized (G).
S. Minardi et al. / Biomaterials 62 (2015) 128e137132phase, and not simplymixedwith hydroxyapatite particles (Fig. S2).
MHA/Coll morphology and structure appeared signiﬁcantly similar
to that of decellularized human trabecular bone, which displayed
comparable ﬁbrous structure and roughness (Fig. 4).3.3. Nano-structural and nano-mechanical characterization of
MHA/Coll
Fig. 5 resembles themeasurements acquired by AFM. Fig. 5A and
B shows Coll and MHA/Coll small bundle of ﬁbers in 2 and 3D
representation. Coll appeared as a compacted and regular grouped
ﬁbers characterized by the typical collagen banding (see arrows in
Fig. 5A) of ~62 nm pattern. MHA/Coll presented a more structured
surface inwhich the banding has been covered by theMHA crystals.
However, a recurrent pattern has been found also MHA/Coll with a
periodicity of ~89 nm. Mean roughness (Ra) of Coll was
18.5 ± 0.8 nm which rose four times in the case of MHA/Coll
(65.95 ± 0.21 nm) as reported in the graph in Fig. 5C. We used a
surface mapping technique called PeakForce QNM AFM in order to
evaluate the nanomechanical features of the ﬁbers of the two
different materials as previously reported [33]. Figs. 5D and E, the
representative sample from Coll and MHA/Coll possessed a similar
modulus distribution, ~2 GPa. However, Coll showed a less ho-
mogenous modulus in comparison with MHA/Coll as evidenced by
the higher standard deviation (Fig. 5F).Fig. 4. SEM micrographs of human trab3.4. hBM-MSC morphology and viability on MHA/Coll
Themorphology of hBM-MSC cultured in 2D conditions (Fig. 6A)
was signiﬁcantly different than that of cells grown on 3D collagen
scaffolds, in which there was apparent alignment along the ﬁbers
(Fig. 6B), in an “Indian ﬁle” conformation (see also magniﬁcation,
Fig. 6C). Cell viability on Coll and MHA/Coll was assessed by LIVE/
DEAD® assay. Cell distribution and organization on the scaffolds
was found to be different between Coll and MHA/Coll. Cells
appeared to align along the pores' wall of both Coll andMHA/Coll at
24h (Figs. 6C and D, respectively). Cells on Coll and MHA/Coll
remained alive for up to 7 days (Fig. 6E and F respectively), with
viability >90% (Fig. 6G).
Cell growth was also assessed at 1 week and compared to hBM-
MSC cultured in 2D conditions (CTRL), as positive control. While
CTRL cells grew at a constant rate over the 7 days, MHA/Coll
showed the lowest rate of cell growth with respect to CTRL and Coll
(less than 40% reduction at 1 week) (Fig. 6H).
3.5. Osteogenic induction in vitro
We cultured hBM-MSCs onto MHA/Coll scaffolds in order to
evaluate the expression of osteogenesis-associated genes (Fig. 7).
The expression levels increased to 78.62 (±4.54)-fold for Bglap,
17.87 (±1.35)-fold for Alp, and 46.12 (±4.55)-fold for Spp1 compared
to the uninduced 2D counterparts (MSC-ctrl) and were found evenecular bone (A) and MHA/Coll (B).
Fig. 5. AeB) 2 and 3D representation of Coll and MHA/Coll images at AFM. The biomineralization of collagen resulted in homogenous mineralized nanoﬁbers assembled of par-
alleled submicroﬁbrils. MHA/Coll showed a recurrent pattern of 89 ± 1.2 nm similar to the gap zones of bare collagen (62 ± 2.2 nm). CeD) Property map of Young's modulus of a
representative sample. Between the arrows is a single collagen nanoﬁber with a low modulus. Asterisk: mica base. B) Property map of Young's modulus of a representative EFM
sample. Cross-banding could be identiﬁed in some ﬁbrils with a different distribution of moduli (open arrowhead versus arrows). C) Property map of Young's modulus of a
representative sample, showing the uniform distribution of the modulus for MHA/Coll. D) Graph represent the Roughness (Ra) Young's modulus of Coll (yellow) and MHA/Coll (red).
(For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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media (MSC-induced). The expression levels in hBM-MSC grown
onto collagen scaffolds (Coll) were comparable to those observed in
uninduced hBM-MSC expanded in 2D conditions.3.6. Ectopic bone formation
There were no surgical complications secondary to the opera-
tions performed and all experimental animals tolerated the pro-
cedure quite well. Over the course of the 6-week postoperative
period, a palpable change in density and ﬁrmness in the implanted
scaffolds could be easily appreciated on gross clinical exam,
conﬁrmed by neutral parties (veterinary technicians within the
HMRI Comparative Medicine Department). As expected, due to the
high porosity of MHA/Coll, with a density slightly higher than that
of air, extracorporeal scaffolds displayed no quantiﬁable volume at
the requisite density thresholds. However, at 24 h post-
implantation, the average volume at 200 HU threshold was
69 mm3 (±9.8), which was used as baseline and all subsequent
measurements had this value subtracted from the total. As ex-
pected, the volume at 500 HU threshold at 24 h was zero. It was
found that MHA/Coll enabled for the production of a large extent of
spongy bone tissue, with a volume of approximately 2 cm3, in just 4
weeks. In details, over the course of the 6-week study period, the
scaffolds demonstrated increasing volumes of bone formation, with
a bell curve distribution of trabecular (200 HU) bone peaking at 4
weeks (818.4 mm3 ± 130.9), before decreasing at 6 weeks to
597.54 mm3 (±176.8) (Fig. 8). Interestingly, this temporal change in
trabecular bone volume inversely mirrors the trend for cortical-type bone (500 HU) throughout the study, which gradually
increased from nearly nothing at 2 weeks (0.80 mm3) to 75.3 mm3
at the ﬁnal time point (Fig. S4).4. Discussion
The present work investigated the osteoinductive potential of a
scaffold mimicking the osteogenic niche of human trabecular bone,
for bone augmentation. MHA/Coll was synthesized through an
innovative biologically inspired process, resembling the main steps
of biomineralization [34]. During material's fabrication, the osteo-
genic niche of newly formed bone is mimicked, by partially
substituting calciumwith magnesium in the apatite lattice. Besides
being poorly crystalline, biological apatite presents substitutions in
the hydroxyapatite lattice structure, and presents doping cations
and anions. Magnesium is the most abundant ion in bone, typically
present in an extent of 5% during osteogenesis (e.g. newly formed
bone, young bone), while it tends to disappear in mature and aging
bone [28]. Therefore, by introducing this ion in apatite's structure, it
is possible to reproduce the conditions found during osteogenesis.
Firstly, the overall morphology of the scaffold, mineral phase
composition and extent were compared to those of human bone.
Secondly, the scaffold's ability to trigger speciﬁc cell functions, such
as cell organization and the expression of osteoblastogenesis-
associated genes in hBM-MSC was studied. Finally, after assessing
its potential to recapitulate the osteogenic niche in vitro, we
investigated the capability of MHA/Coll scaffolds to induce bone
formation in an ectopic model in rabbit.
The process of natural biomineralization in bone is ﬁnely
Fig. 6. Confocal laser micrographs of hBM-MSC seeded in 2D cultures (A), compared with cells cultured in 3D conditions on collagen-based scaffolds (B); magniﬁcation of cell
morphology and organization in 3D culture (C). Fluorescence microscopy images of cells stained with LIVE/DEAD®, seeded on Coll (D, E) and MHA/Coll (F, G) at 24 h and 7 days
respectively. The white arrows indicate few dead cells. Quantiﬁcation of viable cells (H) and cell growth on the scaffolds (I).
Fig. 7. qPCR analysis for the expression of the osteogenic (Alp, Bglap, Ssp1) markers for
hBM-MSC grown in 2D conditions (MSC and induced MSC) and onto scaffolds (Coll and
MHA/Coll). Data are represented as fold-change compared with the expression levels
found in the uninduced MSC. Values are mean ± SD (n ¼ 3). Asterisks depict highly
signiﬁcant differences (P < 0.01).
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mechanisms [35]. The chemical control consists of the precipitation
of ions, naturally present in the bone niche (e.g. Ca2þ,CO32, Naþ,
Kþ), on the organic ECM (mainly collagen), contributing to hy-
droxyapatite crystals' morphology and orientation [36]. The pres-
ence and spatial distribution of functional groups on the template's
surface allows for the structural control over crystals' preferential
growth along collagen ﬁbers, and ﬁnally, a morphologic control
results from the previous control mechanisms, by ensuring a spe-
ciﬁc architecture of the mineral phase up to the macroscale level.
These multiscale control mechanisms ensure the proper homeo-
stasis of bone, at the chemical, physical, morphological and struc-
tural level [34,37]. In this study, scaffold's fabrication differed from
the most common preparation of composite materials, as type I
collagen was dispersed in acetic solution and dropped in the basic
solution of Ca(OH)2 and MgCl2$6H2O. Under these controlled con-
ditions of pH, collagen ﬁbers assembled during the precipitation of
the calcium phosphate phase [34]. This resulted in a composite
material which more closely resembled human trabecular bone's
morphology (Fig. 4). We demonstrated by a direct comparisonwith
human trabecular bone that this MHA/Coll mimics for composition
and overall structure of bone.
The chemical composition of human trabecular bone was also
proven to be closely mimicked by MHA/Coll, by characterization
Fig. 8. DynaCT scan of MHA/Coll seeded subcutaneously in rabbit, at 4 weeks, (A, B, C). Inset in ﬁgure B showed area of cortical bone in the edges of the scaffold, indicated by green
arrows. Bone mass volume formed in the ectopic site in rabbit at 24h, 2, 4 and 6 weeks (D). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred
to the web version of this article.)
S. Minardi et al. / Biomaterials 62 (2015) 128e137 135with XRD. Both spectra presented the typical peaks of hydroxyap-
atite (indicated), and also coincided (Fig. 1A). Our biomimetic
apatite phase presented the same composition and level of crys-
tallinity of that of human bone. MHA spectra were also acquired
after nucleation on highly structured type I collagen through our
bio-inspired process. It resulted in crystallinity signiﬁcantly
decreasing when in the composite MHA/Coll. Collagen, acting as a
template for the nucleation of the crystals of apatite, as in the
natural biomineralization process, prevented their growth,
inducing the formation of nanostructured hydroxyapatite. Low
crystallinity is due not only to the presence of nano-sized crystals,
but also to the incorporation of doping ions (e.g. Mg2þ, CO32,
HPO42) in apatite's lattice, as it occurs in the bone niche, where a
multiplicity of ions are present [30]. Doping ions' role in maintain
the low crystallinity of bone apatite is crucial for bone metabolism
[37]. In fact, the decrease in crystallinity was reported to corre-
spond to higher reactivity in vivo, which determines faster bone
formation and remodeling [38]. The creation of a true MHA/Coll
composite, and of a multisubstituted-apatite phase was conﬁrmed
by FTIR spectroscopy in which we observed a shift of the peak
corresponding to the stretching of eCOO- group of collagen, from
1340 to 1334 cm-1. This switching indicated the binding of MHA
with amid I and/or COO- and form (C]O)2Ca and/or (COO)2Ca
bonds. Also, in MHA/Coll the three characteristic groups of peaks
typical of the carbonation in B position of hydroxyapatite were
spotted (1540, 1455, 1413 and 879-872 cm-1) [39]. A similar pattern
of peaks was observed for bothMHA/Coll and bone, further proving
the high level of biomimicry of MHA/Coll to the natural tissue
(Fig. S3).
Magnesium substitution of calciumwas ﬁnally conﬁrmed by the
Ca/P ratio obtained by ICP analysis, typical of calcium deﬁcient
apatite (1.5e1.67) [40]. Magnesiumwas found to be approximately
the 4 mol%, which is signiﬁcantly similar to that of newly formed
bone. Finally, the overall mineral content in MHA/Coll composite
was found to coincide with that of decellularized human trabecular
bone at approximately 56 wt% (Fig. 5).
Through the biologically inspired mineralization process uti-
lized in this study, we were able to fabricate a composite scaffold
which appeared highly porous, with pores of approximately
100e250 mm in diameter, and an overall anisotropic porosity.
Furthermore, at the microscale level it was difﬁcult to discriminate
between MHA/Coll and human bone trabecular, as they appeared
extremely similar (Fig. 4).
AFM conﬁrmed important structural features of MHA/Coll. Fromthe analysis of ﬁbers nanostructure the crystals of MHA are ho-
mogeneously nucleated along all the ﬁbers, resulting in a higher Ra
induced by the presence of nanocrystals all around collagen sur-
face. In addition the pattern (~89 nm) found in MHA/Coll is prob-
ably due to the fact that MHA substitute water in the gap zones
used the collagen as organic matrix to start the mineral phase
nucleation as well as a natural process of biomineralization [34].
Moreover the presence of the mineral phase affects the nano-
mechanical features of the materials. Although themodulus did not
show signiﬁcant difference between the two samples, a more ho-
mogenous modulus is showed on MHA/Coll ﬁbers. The mechanical
properties of a self-assembled structure strictly depends on the
hierarchical organization of the single compounds [41]. The process
of synthetic biomineralization provided a higher level of hierar-
chical organization resulting in homogenous nanomechanical
features.
Bone is a dynamic organwhere osteoprogenitor cells reorganize
and receive a number of structural, physical and paracrine factors
able to induce osteoblast, osteocyte or osteoclast differentiation
[42,43]. After verifying the resemblance of our material to human
trabecular bone, we assessed the ability of ourmaterial to retain the
functional properties of bone niche and trigger cell speciﬁcation
toward the osteogenic lineage. Despite the cortical [44,45] and
trabecular [46e48] portions of the bone having been recently
suggested as the major reserve of more potent osteoprogenitor
cells, we chose to test this hypothesis using hBM-MSC, due to well-
established isolation and expansion protocols [49e51], and the fact
that they have been extensively designated as the gold standard in
both preclinical and clinical settings [52].
Cells promptly adhered onto the material, which proved to be
biocompatible, and were found completely reorganized few days
after being seeded. On MHA/Coll, however, cell growth was found
lower than Coll. This reinforces the role of our material in reca-
pitulating the osteoblastic niche. In fact, the hypoxic conditions
found in the bone have been proposed to be responsible for
maintaining the cells in a quiescent state [44], and quiescence of
progenitor cells within the niche has been directly linked to their
ability to induce an efﬁcient tissue reconstitution [53]. Consistent
with this, a signiﬁcant increase in the expression of
osteoblastogenesis-associated markers (Spp1 and Bglap) was found
compared with the levels observed in Coll. Interestingly, MHA/Coll
resulted in even higher osteocalcin and osteopontin expression
than the group represented by induced cells following established
in vitro protocols (for p < 0.01).
S. Minardi et al. / Biomaterials 62 (2015) 128e137136Finally, we wanted to verify if this higher level of biomimicry
could allow for more efﬁcient bone formation in vivo, in a large
animal model (rabbit). MHA/Coll's osteinductive potential to form
an extended bone mass more efﬁciently, without the addition of
any bioactive molecule or cells, was evaluated in an ectopic model.
There is a crucial difference between bone formation in an ortho-
topic and ectopic model. In an orthotopic site, bone regeneration
mediated by a scaffold it is strongly facilitated. In fact, after the
creation of the surgical defect and scaffold implantation, follows
the activation of endogenous cascades of signaling pathways that
induce the in situ release of osteogenic GFs [54e56]. The upregu-
lation of these pathways have been demonstrated to be crucial for
bone repair mediated by MSC [57]. Furthermore, in orthotopic
models the scaffolds are exposed to mechanical forces [58], which
has been reported to positively affect the ﬁnal outcome [59]. On the
other hand, there is much evidence that using cellularized scaffold
with BM-MSC, bone formation has been achieved around 8 weeks
[60e62]. More recently, Kinard and coworkers proposed a syn-
thetic biodegradable hydrogel for the delivery of demineralized
bonematrix, to repair a calvarial bone defect in rat (8 mm 1mm).
They obtained the maximum bone mass formation at 12 weeks
[63].
On the contrary, in ectopic models most osteogenic stimuli, such
as cytokines, bone cells, autologous stem cells and mechano-
transduction are eliminated (or signiﬁcantly reduced) [56].
Recently, other signiﬁcant articles about bone augmentation in
rabbit have been published. Kim and coworkers reported the
regeneration of a critical sized calvarial defect in rabbit, in 6 weeks,
by using a polycarbonate scaffold [57]. In this study, we tested our
scaffold in an ectopic model, in order to evaluate its intrinsic
osteoinductive abilities, eliminating the contribution of endoge-
nous osteogenic stimuli in rabbit that showed a similar mineral
density to the human bone in comparison to other rodents models
[64].
The most striking in vivo result was the dramatic mass
(approximately 2 cm  1 cm x 1 cm) of bone formed in only 2
weeks, which is a third or even a sixth (depending on the material
and animal model) of the time usually necessary for scaffolds to
produce bone-like tissue. Remarkably, these results were achieved
without the contribution of endogenous cytokines (since the scaf-
fold was implanted subcutaneously), heterologous cytokines, or
addition of progenitor cells on the scaffold. Furthermore, the
maturation of this bone mass initiated at only 6 weeks.
To our knowledge, this study reports for the ﬁrst time the for-
mation of extend mass of trabecular bone in an ectopic model in
large animal by an innovative composite scaffold. This study rep-
resents a signiﬁcant accomplishment for the ﬁeld of bone
augmentation, as no robust off-the-shelf approach is currently
available.
5. Conclusions
In this study MHA/Coll composite scaffold was synthesized
through an innovative biologically inspired process, resembling the
main steps of the biomineralization. It was investigated if such
synthetic material could mimic the osteogenic niche at the chem-
ical, physical, morphological and biological level, and its potential
was ultimately assessed in a large animal model.
Altogether, data reported in this study represents a signiﬁcant
step in the development of acellular off-the-shelf substitutes for
applications of bone augmentation. By simply mimicking the
osteogenic niche from the nanoscale up to the macroscale of the
bone ECM, this scaffold was shown to actively induce stem cells
osteogenic speciﬁcation in vitro, while providing an osteo-
conductive environment for tissue remodeling. This approachwould signiﬁcantly impact the orthopedic ﬁeld, as it represents a
robust alternative to the currently available materials, and to the
use of osteoinductive molecules, such as human recombinant BMP-
2 whose use is still highly controversial.
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